Thank you to our Exhibitors & Sponsors!

AbbVie is driving the pursuit of improved mental health. Over the last 30 years, the company’s scientists and clinicians have worked to tackle the complexity of mental illness and today offer a portfolio of medicines and a pipeline of innovation that spans depression, anxiety, bipolar disorder, and schizophrenia. To learn more about AbbVie’s work to support individuals throughout their mental health journey, please visit www.abbvie.com or follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

American Professional Agency, Inc., (APA, Inc.) holds the unique distinction of being the endorsed professional liability carrier of the APA as well as the endorsed sponsor for AACAP.    We earned this honor through a combination of product offerings and services that are best in class.  These include:

·        Policies and options offered to meet your needs.

·        24 hour access to risk management professionals.

·        Policy discounts for new policy holders, part time professionals and policy holders who complete on line risk management CME courses.

·        CME webinars offered in partnership with APA District Branches.

We have been in business for 65 years and we insure all mental health professionals.  We pride ourselves on our excellent customer service.  Please feel free to contact us if we can answer any questions- 800-421-6694.  We thank you for your many years of support and look forward to working with you.

Christine Cotter

Vice President, Public Relations

American Professional Agency, Inc.

240-888-9355

ccotter@americanprofessional.com

At Janssen, the Pharmaceutical Companies of Johnson & Johnson, we’re creating a future where disease is a thing of the past. We tackle society’s most pressing health challenges, connecting big ideas to the resources we need to make them a reality. Our goal is to advance access to good health for all. By seeking out medical breakthroughs wherever they occur, leveraging internal expertise and embracing external science, we aim to bring the best solutions to the people who need them.

We focus on areas of medicine where we can make the biggest difference: 

• Cardiovascular & Metabolism

• Immunology

• Infectious Diseases & Vaccines

• Neuroscience

• Oncology

• Pulmonary Hypertension 

With approximately 41,700 employees in more than 150 countries around the world, we rise to the challenge each day in pursuit of a healthier future for every person.

The complex, global healthcare landscape presents new challenges, new diseases and new dynamics. That’s why we focus our efforts and resources where the need is high, the science is compelling and where we have the greatest opportunity to save and improve lives. We must work together – across business, academia, governments and society – to lead healthcare’s ongoing reinvention. At Janssen, we collaborate with the world for the health of everyone in it.

For Janssen, it is not just about leading innovation and driving medical breakthroughs. We go beyond the medicine by working with patients through the entire process to ensure the best possible experience and health outcomes. We are driven by our belief that “patients are waiting” and there is no time to waste.

For nearly a century, we have fearlessly confronted the world’s most devastating and complex diseases. We continue to wage this fight with more strength, determination and expertise than ever before. We are all in until society’s most daunting diseases are found only in the pages of history books and good health is in reach for all of humanity.

To learn more, visit our website https://www.janssen.com/

Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. With patients at the center of everything it does, Sunovion has an unwavering commitment to support people with psychiatric, neurological and respiratory conditions. Visit us at www.sunovion.com.

Otsuka America Pharmaceutical, Inc. (OAPI) is an innovative healthcare company that commercializes Otsuka-discovered and in-licensed products in the U.S., with a focus on neuroscience, nephrology, and medical devices. 

For more information, visit https://www.otsuka-us.com/home.

Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of CNS healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.

Practice alongside other civilian and military health care professionals at locations across the U.S. and around the world and experience the unique professional opportunities* and benefits that can be found with the Defense Health Agency.

The U.S. Defense Health Agency (DHA) is comprised of civilian health care professionals employed by the U.S. Government. DHA employees serve our country by caring for military service members but are not subject to military requirements such as "boot camp," military uniforms, or deployment.

*U.S. Citizenship Required

Operating through 148 Company-operated treatment centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 730,000 TMS treatments to over 20,000 patients struggling with depression.

Intra-Cellular Therapies is a biopharmaceutical company founded on Dr. Paul Greengard’s Nobel Prize-winning research that uncovered how therapies affect the inner-working of cells in the body.

We leverage this intracellular approach to deliver treatments that will be transformative for people living with complex psychiatric and neurologic diseases.

MindPeace Clinics specializes in Ketamine Therapeutics, including intravenous ketamine and Spravato (Esketamine), to treat patients with Treatment Resistant Mood Disorders.  We have three locations to better serve our patients, in the DC Metro, Central Virginia and Tidewater areas. 

PRMS® manages The Psychiatrists’ Program®, a full-service medical professional liability insurance program for behavioral healthcare providers. Unparalleled in its risk management expertise, aggressive defense strategies, and specialized policy, the program includes telepsychiatry and forensic coverage at no cost, and license defense coverage up to $150,000.*

*May vary by state.